-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Perspective Therapeutics, Maintains $14 Price Target

Benzinga·01/13/2026 12:24:12
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Perspective Therapeutics (AMEX:CATX) with a Buy and maintains $14 price target.